Kimberly-Clark (KMB) Projected to Post Quarterly Earnings on Friday

Kimberly-Clark (NYSE:KMB) is expected to issue its Q2 2025 quarterly earnings data before the market opens on Friday, August 1st. Analysts expect the company to announce earnings of $1.67 per share and revenue of $4.85 billion for the quarter.

Kimberly-Clark Stock Performance

Shares of NYSE KMB opened at $125.29 on Thursday. The company has a current ratio of 0.80, a quick ratio of 0.54 and a debt-to-equity ratio of 7.05. Kimberly-Clark has a 12 month low of $124.10 and a 12 month high of $150.45. The stock has a 50 day moving average of $132.08 and a 200-day moving average of $134.54. The company has a market capitalization of $41.57 billion, a P/E ratio of 16.59, a P/E/G ratio of 4.46 and a beta of 0.35.

Insiders Place Their Bets

In other Kimberly-Clark news, insider Katy Chen sold 740 shares of Kimberly-Clark stock in a transaction on Friday, May 2nd. The stock was sold at an average price of $129.70, for a total value of $95,978.00. Following the completion of the transaction, the insider directly owned 3,997 shares of the company’s stock, valued at $518,410.90. The trade was a 15.62% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. 0.64% of the stock is owned by corporate insiders.

Hedge Funds Weigh In On Kimberly-Clark

A hedge fund recently raised its stake in Kimberly-Clark stock. Brighton Jones LLC grew its holdings in Kimberly-Clark Co. (NYSE:KMB) by 74.1% during the 4th quarter, according to the company in its most recent filing with the SEC. The fund owned 6,494 shares of the company’s stock after purchasing an additional 2,765 shares during the period. Brighton Jones LLC’s holdings in Kimberly-Clark were worth $851,000 as of its most recent SEC filing. Institutional investors and hedge funds own 76.29% of the company’s stock.

Analyst Upgrades and Downgrades

Several analysts recently weighed in on the company. JPMorgan Chase & Co. dropped their price target on Kimberly-Clark from $126.00 to $125.00 and set an “underweight” rating for the company in a report on Friday, July 25th. Piper Sandler assumed coverage on Kimberly-Clark in a report on Friday, July 18th. They set an “overweight” rating and a $144.00 price target for the company. Barclays dropped their price target on Kimberly-Clark from $135.00 to $134.00 and set an “equal weight” rating for the company in a report on Tuesday, July 15th. Wall Street Zen cut Kimberly-Clark from a “buy” rating to a “hold” rating in a report on Thursday, April 24th. Finally, UBS Group dropped their price target on Kimberly-Clark from $146.00 to $139.00 and set a “neutral” rating for the company in a report on Thursday, July 17th. Two research analysts have rated the stock with a sell rating, six have assigned a hold rating and three have given a buy rating to the stock. According to MarketBeat.com, Kimberly-Clark presently has an average rating of “Hold” and an average price target of $140.90.

About Kimberly-Clark

Kimberly-Clark Corporation, together with its subsidiaries, manufactures and markets personal care and consumer tissue products in the United States. It operates through three segments: Personal Care, Consumer Tissue, and K-C Professional. The company’s Personal Care segment offers disposable diapers, training and youth pants, swimpants, baby wipes, feminine and incontinence care products, reusable underwear, and other related products under the Huggies, Pull-Ups, Little Swimmers, GoodNites, DryNites, Sweety, Kotex, U by Kotex, Intimus, Thinx, Poise, Depend, Plenitud, Softex, and other brand names.